ANALYSIS OF TOTAL COSTS OF BREAST CANCER CEMOTHERAPY PATIENTS BASED ON USE OF CHEMOTHERAPY REGIMEN ON JKN PATIENTS IN SANGLAH RSUP



Ni Putu Wintariani, Ni Made Okadwicandra, Abdul Khodir Jaelani

Abstract


Breast cancer is the first sequence of most attacking women in Indonesia. The high cost of care and old services is a major problem in the prevention of breast cancer. This study aims to determine the relationship between the total cost of the Sanglah Denpasar hospital with the chemotherapy regimen of breast cancer of JKN patients at Sanglah Hospital Denpasar. Test homogeneity using Levene test method. Test normality using Kolmogorov-Smirnov. One way ANOVA test results showed a significant relationship between chemotherapy therapy regimen (FAC, FAC + PAXUS, FEC, AC, AC + PAXUS) with total real cost in breast cancer chemotherapy patients (p = 0.001). The total rill cost was greater in the group receiving FAC + PAXUS, FEC, and AC + PAXUS regimens than the group receiving FAC and AC therapy regimens. This can be caused by a large pharmaceutical cost component in the FAC + PAXUS, FEC, and AC + PAXUS groups. Pharmaceutical costs account for 76.84-85.80% of the total real cost of breast cancer patients receiving chemotherapy. More drug combination factors can lead to higher total rill costs in patients receiving FAC + PAXUS, FEC, and AC + PAXUS.


Keywords


Chemotherapy; Breast Cancer; JKN; Chemotherapy Regiment

Full Text:

PDF INDONESIA

Article Statistics

Abstract View : 0 Times
PDF INDONESIA : 0 Downloaded

References


Andayani, T. M.. 2013. Farmakoekonomi Prinsip dan Metodelogi. Cetakan pertama. Yogyakarta: Bursa ILmu. Hal 20-24.

Bootman, J. L., Townsend, R. J.. McGhan, W. F. 2005. Principles of Pharmacoeconomics. Harvey Whitney Books Company. Ohio. Hal 1-18.

Corwin, J.E., 2000, Patofisiologi (Handbook of Pathophysiology), Jakarta : Penerbit Buku Kedokteran EGC.

Depkes RI, 2014, Jika Tidak dikendalikan 26 Juta Orang di Dunia Menderita Kanker, http://www.depkes.go.id[ 2 Maret 2017 ].

Depkes RI, 2014, JKN Menjamin Pemeriksaan Deteksi Dini Kanker Leher Rahim dan Payudara, http://www.depkes.go.id [2 Maret 2017].

Depkes RI, 2014, Pemerintah Targetkan 80% Perempuan dapat Deteksi Dini Kanker Payudara,http://www.depkes.go.id [ 2 Maret 2017 ].

Dipiro, J.T. et al, 2008,Pharmacotherapy : A Pathophysiologic Approach 9th Edition

Emilia, O.. 2010. Bebas Ancaman Kanker Serviks. Media Presindo. Yogyakarta

Hassett M.J., O’Malley A.J., Pakes J.R., Newhouse J.P., Earle C.C., 2006, Frequency and Cost of Chemotherapy-Related Serious Adverse Effects in a Population Sample of Women WithBreast Cancer, Journal of the National Cancer Institute, Volume 98, No. 16. [19 april 2017].

Medicastrore, 2014, Kanker Payudara, http://medicastore.com [ 19 april 2017 ].

NCCN, 2012, Clinical Pactice Guidelines in Oncology (NCCN Guidelines) : Breast Cancer, http://www.nccn.com [19 april 2017].

Otto, S. E., 2005, Buku Saku Keperawatan Onkologi, Jakarta : Penerbit Buku Kedokteran.

Paviot B.T., Bachelot T., Clavreul G., Jacquin J.P., Mille D., Rodrigues J.M., 2009,Impact of the chemotherapy protocols for metastatic breast cancer on the treatment cost and the survival time of 371 patients treated in three hospitals of the Rhone-Alpes region, DOI.

Kemenkes RI, 2014, http://kanker.kemkes.go.id/guidelines/PPKPayudara.pdf., [19 april 2017].




Copyright (c) 2017 Jurnal Endurance

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Published by Kopertis Wilayah X

Khatib Sulaiman Street Padang
West Sumatera
Phone: +62751705637
Fax: +62751705637
Email: [email protected]

E-ISSN : 2477-6521
Copyright (c) 2017 Kopertis Wilayah X (Sumbar, Jambi, Riau dan Kep. Riau)